Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report

We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received a...

Descripción completa

Detalles Bibliográficos
Autores principales: Medhat, R., El Lababidi, R., Abdelsalam, M., Nusair, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058432/
https://www.ncbi.nlm.nih.gov/pubmed/35398296
http://dx.doi.org/10.1016/j.ijid.2022.04.001
_version_ 1784698111682150400
author Medhat, R.
El Lababidi, R.
Abdelsalam, M.
Nusair, A.
author_facet Medhat, R.
El Lababidi, R.
Abdelsalam, M.
Nusair, A.
author_sort Medhat, R.
collection PubMed
description We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination.
format Online
Article
Text
id pubmed-9058432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-90584322022-05-02 Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report Medhat, R. El Lababidi, R. Abdelsalam, M. Nusair, A. Int J Infect Dis Case Report We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-06 2022-04-06 /pmc/articles/PMC9058432/ /pubmed/35398296 http://dx.doi.org/10.1016/j.ijid.2022.04.001 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Medhat, R.
El Lababidi, R.
Abdelsalam, M.
Nusair, A.
Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title_full Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title_fullStr Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title_full_unstemmed Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title_short Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report
title_sort varicella-zoster virus (vzv) meningitis in an immunocompetent adult after bnt162b2 mrna covid-19 vaccination: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058432/
https://www.ncbi.nlm.nih.gov/pubmed/35398296
http://dx.doi.org/10.1016/j.ijid.2022.04.001
work_keys_str_mv AT medhatr varicellazostervirusvzvmeningitisinanimmunocompetentadultafterbnt162b2mrnacovid19vaccinationacasereport
AT ellababidir varicellazostervirusvzvmeningitisinanimmunocompetentadultafterbnt162b2mrnacovid19vaccinationacasereport
AT abdelsalamm varicellazostervirusvzvmeningitisinanimmunocompetentadultafterbnt162b2mrnacovid19vaccinationacasereport
AT nusaira varicellazostervirusvzvmeningitisinanimmunocompetentadultafterbnt162b2mrnacovid19vaccinationacasereport

Ejemplares similares